An analysis of data on the incidence of pertussis shows that although acellular pertussis (Tdap) vaccine had a positive impact among adolescents in the 4 years after it was introduced in 2005, in 2010 pertussis incidence in this age group began to increase more rapidly than it did in all other age groups.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a nationally representative survey published in Clinical Pediatrics. The survey asked parents what they wanted to know about vaccines and how they wanted providers to handle their concerns.
Physicians who opt against recommending HPV vaccination because they assume their patient is too young or not sexually active, or that the parent will refuse, are missing an opportunity to protect against a dangerous virus, according to a new study.
Outbreaks of vaccine-preventable diseases like measles and pertussis have led pediatricians to take a hard line, sometimes dismissing patients who are non-compliant with immunizations. A new study examines the prevalence—and consequences—of patient dismissal.
The currently recommended childhood immunization schedule put forth by the Centers for Disease Control and Prevention (CDC) is designed to protect infants and young children from 14 harmful and potentially deadly diseases before a child’s second birthday.
Many pediatricians believe that if they pay $30 for an immunization, as long as a payer reimburses them more than $30, they’re OK, said Chip Hart. The fact is, that’s not the case, he explained during his presentation “The Business of Immunization: Protecting Kids without Destroying Your Practice.”
Women who receive the prophylactic bivalent human papilloma virus (HPV) vaccine within 90 days of pregnancy are not at an increased risk for miscarriage, underscoring the safety of the vaccine. The proven safety of the bivalent HPV vaccine should quell the concerns of women and their health care practitioners.